Targeted, triggered drug delivery to tumor and biofilm microenvironments

References

• 1 Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 12(11), 991–1003 (2013).
  Medline CASGoogle Scholar
• 2 Petros RA, Desimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov. 9(8), 615–627 (2010).
  Medline CASGoogle Scholar
• 3 Lebeaux D, Chauhan A, Letoffe S et al. pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms. J. Infect. Dis. 210(9), 1357–1366 (2014).
  MedlineGoogle Scholar
• 4 Lebeaux D, Ghigo JM, Beloin C. Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol. Mol. Biol. Rev. 78(3), 510–543 (2014).
  Medline CASGoogle Scholar
• 5 Torchilin VP. Multifunctional nanocarriers. Adv. Drug Del. Rev. 64, 302–315 (2012).
  Google Scholar
• 6 Upreti M, Jyoti A, Sethi P. Tumor microenvironment and nanotherapeutics. Transl. Cancer Res. 2(4), 309–319 (2013).
  Medline CASGoogle Scholar
• 7 Forier K, Raemdonck K, De Smedt SC, Demeester J, Coenye T, Braeckmans K. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms. J. Control. Release 190, 607–623 (2014).
  Medline CASGoogle Scholar
• 8 Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 196(4), 395–406 (2012).
  Medline CASGoogle Scholar
• 9 Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2(2), 95–108 (2004).
  Medline CASGoogle Scholar
• 10 Flemming HC, Wingender J. The biofilm matrix. Nat. Rev. Microbiol. 8(9), 623–633 (2010).
  Medline CASGoogle Scholar
• 11 Koo H, Falsetta ML, Klein MI. The exopolysaccharide matrix: a virulence determinant of cariogenic biofilm. J. Dent. Res. 92(12), 1065–1073 (2013).
  Medline CASGoogle Scholar
• 12 Stewart PS, Franklin MJ. Physiological heterogeneity in biofilms. Nat. Rev. Microbiol. 6(3), 199–210 (2008).
  Medline CASGoogle Scholar
• 13 Iyer AK, Khaled G, Fang J, Maeda H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov. Today 11(17–18), 812–818 (2006).
  Medline CASGoogle Scholar
• 14 Azzopardi EA, Ferguson EL, Thomas DW. The enhanced permeability retention effect: a new paradigm for drug targeting in infection. J. Antimicrob. Chemother. 68(2), 257–274 (2013).
  Medline CASGoogle Scholar
• 15 Barua S, Mitragotri S. Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects. Nano Today 9(2), 223–243 (2014).
  Medline CASGoogle Scholar
• 16 Upadhyay M, Samal J, Kandpal M, Singh OV, Vivekanandan P. The Warburg effect: insights from the past decade. Pharmacol. Ther. 137(3), 318–330 (2013).
  Medline CASGoogle Scholar
• 17 Schmaljohann D. Thermo- and pH-responsive polymers in drug delivery. Adv Drug Deliv. Rev. 58(15), 1655–1670 (2006).
  Medline CASGoogle Scholar
• 18 Wouters A, Pauwels B, Lardon F, Vermorken JB. Review: implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions. Oncologist 12(6), 690–712 (2007).
  Medline CASGoogle Scholar
• 19 Simmen HP, Blaser J. Analysis of pH and pO2 in abscesses, peritoneal fluid, and drainage fluid in the presence or absence of bacterial infection during and after abdominal surgery. Am. J. Surg. 166(1), 24–27 (1993).
  Medline CASGoogle Scholar
• 20 Horev B, Klein MI, Hwang G et al. pH-activated nanoparticles for controlled topical delivery of farnesol to disrupt oral biofilm virulence. ACS Nano 9(3), 2390–2404 (2015).
  Medline CASGoogle Scholar
• 21 Radovic-Moreno AF, Lu TK, Puscasu VA, Yoon CJ, Langer R, Farokhzad OC. Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics. ACS Nano 6(5), 4279–4287 (2012).
  Medline CASGoogle Scholar
• 22 Zhu YJ, Chen F. pH-responsive drug-delivery systems. Chem. Asian J. 10(2), 284–305 (2015).
  Medline CASGoogle Scholar
• 23 Liu J, Huang Y, Kumar A et al. pH-sensitive nano-systems for drug delivery in cancer therapy. Biotechnol. Adv. 32(4), 693–710 (2014).
  Medline CASGoogle Scholar
• 24 Thambi T, Deepagan VG, Yoon HY et al. Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery. Biomaterials 35(5), 1735–1743 (2014).
  Medline CASGoogle Scholar
• 25 Perche F, Biswas S, Wang T, Zhu L, Torchilin VP. Hypoxia-targeted siRNA delivery. Angew. Chem. Int. Ed. Engl. 53(13), 3362–3366 (2014).
  Medline CASGoogle Scholar